TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
OGN

Organon & Co

Healthcare · Drug Manufacturers - General

13.70$ -0.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement OGN
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
43.7% 48.0% 29.2% 32.4% 37.8% 37.2% 40.2% 42.0% 45.9%
56.3% 52.0% 70.8% 67.6% 62.2% 62.8% 59.8% 58.0% 54.1%
3.4% 3.7% 2.8% 3.2% 7.0% 7.6% 8.4% 7.3% 5.9%
18.4% 17.3% 15.2% 17.7% 22.7% 23.5% 26.9% 24.3% 27.7%
25.1% 24.3% 21.4% 24.0% 31.8% 35.2% 38.7% 34.8% 33.6%
31.2% 27.7% 49.5% 43.6% 30.4% 27.6% 21.2% 23.2% 20.7%
0.2% 0.5% 0.1% 0.1% 4.1% 6.8% 8.4% 8.1% 8.1%
29.5% 27.9% 47.5% 42.1% 24.3% 18.2% 10.7% 12.6% 6.8%
12.4% 5.9% 5.0% 7.6% 2.8% 3.3% -5.6% -0.9% 3.8%
17.2% 22.0% 41.4% 33.1% 21.4% 14.9% 16.3% 13.5% 3.0%
48.4% 44.8% 50.3% 45.8% 31.4% 28.4% 22.9% 25.1% 20.6%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?